Scientists in the United Kingdom say that two doses of the conventional vaccine are not enough to prevent coronary amyotrophic lateral sclerosis. However, the third dose increases the protection against the type to about 75 percent, they said. News from the BBC.
It was feared from the outset that the conventional vaccine against immunization would not be as effective. A similar study in the United Kingdom on amicron and delta types yielded similar information. However, the UK’s Health Security Agency (UKHSA) says the coronavirus vaccine is able to prevent hospital admissions after being exposed to antimicrobials, despite reduced protection.
To verify the effectiveness of the vaccine against Amicron, scientists in the United Kingdom studied 581 people infected with the virus and several thousand people infected with the delta. There, the effectiveness of the Oxford-AstraZeneca vaccine has decreased dramatically. After taking two doses of the Pfizer vaccine, the protection rate was found to be significantly reduced. However, studies have shown that taking the third dose of vaccines increases the protection against corona to 70 to 85 percent.
The UKHSA estimates that half of all corona infections in the UK will be transmitted through emissions by the middle of this month. More than 1 million people in the UK will be infected with the virus by the end of the month if the strain is not curbed.
Mary Ramsay, head of the UKHSA Immunization Unit, said: This indicates a higher risk of developing amygdala than delta after taking the second dose of the vaccine.